| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200161 | Ophthalmology | 2016 | 9 Pages |
Abstract
We found no important difference in effectiveness or safety between bevacizumab and ranibizumab for NVAMD treatment, but there was a large cost difference.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Sharon D. MD, Kristina B. MS, Magdalena G. MD, Satyanarayana S. MBBS, PhD, Barbara S. PhD,